Credit Suisse’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$455K Buy
+44,599
New +$455K ﹤0.01% 2670
2023
Q2
Sell
-41,372
Closed -$175K 3150
2023
Q1
$175K Buy
41,372
+3,235
+8% +$13.7K ﹤0.01% 3127
2022
Q4
$627K Buy
+38,137
New +$627K ﹤0.01% 2623
2022
Q3
Sell
-21
Closed 4005
2022
Q2
$0 Buy
+21
New ﹤0.01% 3880
2021
Q4
Sell
-1,410,397
Closed -$16M 3613
2021
Q3
$16M Sell
1,410,397
-19,378
-1% -$219K 0.01% 900
2021
Q2
$14.1M Buy
1,429,775
+515,336
+56% +$5.08M 0.01% 991
2021
Q1
$12.9M Sell
914,439
-279,280
-23% -$3.95M 0.01% 1049
2020
Q4
$13.5M Buy
+1,193,719
New +$13.5M 0.01% 987
2017
Q3
Sell
-449
Closed -$43K 3674
2017
Q2
$43K Buy
+449
New +$43K ﹤0.01% 3394
2017
Q1
Sell
-263
Closed -$256K 3414
2016
Q4
$256K Buy
263
+184
+233% +$179K ﹤0.01% 3362
2016
Q3
$68K Sell
79
-10
-11% -$8.61K ﹤0.01% 3638
2016
Q2
$65K Buy
+89
New +$65K ﹤0.01% 3814
2015
Q2
Sell
-85
Closed -$42K 4208
2015
Q1
$42K Buy
+85
New +$42K ﹤0.01% 4007